Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort
暂无分享,去创建一个
M. Emoto | M. Inaba | A. Shintani | T. Shoji | D. Kabata | K. Mori | Y. Tsujimoto | S. Nakatani | A. Shioi | Shoko Tsuchikura | Yujiro Okute | Keyaki Sasaki | Naoko Shimomura
[1] S. Yamagishi,et al. Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study , 2020, Diabetes Therapy.
[2] H. Brenner,et al. Association of Serum Markers of Oxidative Stress With Incident Major Cardiovascular Events, Cancer Incidence, and All-Cause Mortality in Type 2 Diabetes Patients: Pooled Results From Two Cohort Studies , 2019, Diabetes Care.
[3] J. McMurray,et al. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. , 2019, The New England journal of medicine.
[4] N. Yorioka,et al. Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial , 2018, JAMA.
[5] H. Brenner,et al. Association of serum markers of oxidative stress with myocardial infarction and stroke: pooled results from four large European cohort studies , 2018, European Journal of Epidemiology.
[6] S. Fukumoto,et al. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients. , 2018, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[7] M. Emoto,et al. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients , 2017, Journal of atherosclerosis and thrombosis.
[8] L. Benítez-Bribiesca,et al. Impact of Oxidative Stress in Premature Aging and Iron Overload in Hemodialysis Patients , 2016, Oxidative medicine and cellular longevity.
[9] S. Fukuhara,et al. Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation , 2016, Clinical and Experimental Nephrology.
[10] C. Wanner,et al. The heart and vascular system in dialysis , 2016, The Lancet.
[11] H. Brenner,et al. Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data , 2015, BMC Medicine.
[12] Wanchun Tang,et al. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition , 2015, Journal of the American Heart Association.
[13] P. Stenvinkel,et al. Oxidative DNA Damage and Mortality in Hemodialysis and Peritoneal Dialysis Patients , 2015, Peritoneal Dialysis International.
[14] S. Fukumoto,et al. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] H. Arima,et al. Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] S. Fukumoto,et al. Decreased serum adrenal androgen dehydroepiandrosterone sulfate and mortality in hemodialysis patients. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] M. Kohno,et al. Significance of measuring oxidative stress in lifestyle-related diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects , 2011, Hypertension Research.
[18] H. Koyama,et al. Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate , 2010, BMC nephrology.
[19] P. G. Wells,et al. Prostaglandin H synthase-1-catalyzed bioactivation of neurotransmitters, their precursors, and metabolites: oxidative DNA damage and electron spin resonance spectroscopy studies. , 2009, Chemical research in toxicology.
[20] Gert Mayer,et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.
[21] D. Tarng,et al. GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients. , 2009, Journal of the American Society of Nephrology : JASN.
[22] D. Tarng,et al. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. , 2008, Journal of the American Society of Nephrology : JASN.
[23] S. Hazen,et al. Serum myeloperoxidase and mortality in maintenance hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] C. Boni,et al. Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease. , 2006, International journal of cardiology.
[25] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[26] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[27] F. Berrino,et al. Evaluation of reactive oxygen metabolites in frozen serum samples. Effect of storage and repeated thawing. , 2004, The International journal of biological markers.
[28] T. Ikizler,et al. Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. , 2004, Kidney international.
[29] J. Morrow,et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. , 2004, Kidney international.
[30] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.
[31] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[32] C. Wanner,et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] M. Emoto,et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. , 2002, Kidney international.
[34] L. Sugherini,et al. Plasma Total Antioxidant Capacity in Hemodialyzed Patients and Its Relationships to other Biomarkers of Oxidative Stress and Lipid Peroxidation , 2002, Clinical chemistry and laboratory medicine.
[35] V. Fogliano,et al. Use of N, N -dimethyl- p -phenylenediamine to Evaluate the Oxidative Status of Human Plasma , 2002, Free radical research.
[36] M. Emoto,et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. , 2001, Journal of the American Society of Nephrology : JASN.
[37] J. Blumberg,et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. , 2001, Kidney international.
[38] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[39] A. Nicolaides,et al. A simple test to monitor oxidative stress. , 1999, International angiology : a journal of the International Union of Angiology.
[40] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[41] P. Jungers,et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.
[42] H. Sies,et al. Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.